TW204353B - - Google Patents

Download PDF

Info

Publication number
TW204353B
TW204353B TW079106165A TW79106165A TW204353B TW 204353 B TW204353 B TW 204353B TW 079106165 A TW079106165 A TW 079106165A TW 79106165 A TW79106165 A TW 79106165A TW 204353 B TW204353 B TW 204353B
Authority
TW
Taiwan
Prior art keywords
coli
toxin
page
patent application
vaccine
Prior art date
Application number
TW079106165A
Other languages
English (en)
Chinese (zh)
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Application granted granted Critical
Publication of TW204353B publication Critical patent/TW204353B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
TW079106165A 1989-08-18 1990-07-25 TW204353B (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89202110 1989-08-18

Publications (1)

Publication Number Publication Date
TW204353B true TW204353B (https=) 1993-04-21

Family

ID=8202455

Family Applications (1)

Application Number Title Priority Date Filing Date
TW079106165A TW204353B (https=) 1989-08-18 1990-07-25

Country Status (16)

Country Link
US (1) US5750115A (https=)
EP (1) EP0413378B1 (https=)
JP (1) JP3031561B2 (https=)
KR (1) KR0177510B1 (https=)
CN (1) CN1062605C (https=)
AU (1) AU635062B2 (https=)
CA (1) CA2022420C (https=)
DE (1) DE69016129T2 (https=)
DK (1) DK0413378T3 (https=)
ES (1) ES2070266T3 (https=)
GR (1) GR3015782T3 (https=)
HU (2) HU210965B (https=)
IL (1) IL95175A (https=)
NZ (1) NZ234933A (https=)
TW (1) TW204353B (https=)
ZA (1) ZA906100B (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3871489D1 (de) * 1987-10-26 1992-07-02 Akzo Nv Impfstoff gegen e.coli-blutvergiftung bei gefluegel.
WO1998051217A1 (en) * 1997-05-16 1998-11-19 Medical Defense Technologies, Llc Vaccine against lipopolysaccharide core
US6749831B1 (en) 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
IL139538A0 (en) * 1998-05-15 2004-02-08 Mkb Invest Ltd Partnership Compositions and method for immunizing poultry
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
JP5085547B2 (ja) * 2005-08-30 2012-11-28 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション 生理活性ポリペプチドの細菌性送達
CA2781866C (en) 2009-10-12 2019-12-03 New Health Sciences, Inc. Blood storage bag system and depletion devices with oxygen and carbon dioxide depletion capabilities
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
CN102905522A (zh) 2009-10-12 2013-01-30 新健康科学股份有限公司 用于从红细胞中除去氧的氧消耗装置和方法
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US12089589B2 (en) 2009-10-12 2024-09-17 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US9339025B2 (en) 2010-08-25 2016-05-17 New Health Sciences, Inc. Method for enhancing red blood cell quality and survival during storage
PT2635114T (pt) 2010-11-05 2020-06-16 New Health Sciences Inc Irradiação de glóbulos vermelhos e armazenamento anaeróbico
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
WO2013009843A1 (en) * 2011-07-11 2013-01-17 Camas Incorporated Compositions against bacterial toxins
ES2984863T3 (es) 2011-08-10 2024-10-31 Hemanext Inc Dispositivo integrado de filtrado de leucocitos, oxígeno y/o agotamiento de CO2, y separación de plasma
ES2900298T3 (es) 2013-02-28 2022-03-16 Hemanext Inc Dispositivo de agotamiento de gas para productos sanguíneos
PT3970731T (pt) 2015-03-10 2026-02-24 Hemanext Inc Kits descartáveis de redução de oxigénio, dispositivos e métodos de utilização dos mesmos
WO2016172645A1 (en) 2015-04-23 2016-10-27 New Health Sciences, Inc. Anaerobic blood storage containers
CA2985799A1 (en) 2015-05-18 2016-11-24 New Health Sciences, Inc. Methods for the storage of whole blood, and compositions thereof
KR20240132129A (ko) 2016-05-27 2024-09-02 헤마넥스트 인코포레이티드 혐기성 혈액 저장 및 병원체 불활성화 방법
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof
US12138302B2 (en) 2020-10-27 2024-11-12 Pfizer Inc. Escherichia coli compositions and methods thereof
US12357681B2 (en) 2020-12-23 2025-07-15 Pfizer Inc. E. coli FimH mutants and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58135819A (ja) * 1982-02-09 1983-08-12 Nisshin Flour Milling Co Ltd 鶏の大腸菌症の予防法
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4702911A (en) 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
EP0237045B1 (en) * 1986-03-11 1993-10-20 Shionogi & Co., Ltd. DNA encoding flagellin and vector having the same

Also Published As

Publication number Publication date
HU210965B (en) 1995-09-28
EP0413378A1 (en) 1991-02-20
AU635062B2 (en) 1993-03-11
NZ234933A (en) 1992-06-25
US5750115A (en) 1998-05-12
CA2022420A1 (en) 1991-02-19
IL95175A (en) 1994-05-30
EP0413378B1 (en) 1995-01-18
DE69016129T2 (de) 1995-05-24
CN1049523A (zh) 1991-02-27
JP3031561B2 (ja) 2000-04-10
ZA906100B (en) 1991-05-29
GR3015782T3 (en) 1995-07-31
HU211827A9 (en) 1995-12-28
DK0413378T3 (da) 1995-05-15
AU6109990A (en) 1991-02-21
CN1062605C (zh) 2001-02-28
HUT59612A (en) 1992-06-29
DE69016129D1 (de) 1995-03-02
ES2070266T3 (es) 1995-06-01
KR0177510B1 (ko) 1999-03-20
JPH03184996A (ja) 1991-08-12
CA2022420C (en) 2000-03-28
KR910004209A (ko) 1991-03-28
HU905053D0 (en) 1991-01-28
IL95175A0 (en) 1991-06-10

Similar Documents

Publication Publication Date Title
TW204353B (https=)
US20210347858A1 (en) Alimentary and systemic antiviral therapeutics
ES2534332T3 (es) Composiciones que incluyen hemaglutinina, métodos de preparación y métodos de uso de las mismas
ES2594102T3 (es) Mutantes por deleción de la flagelina y métodos para su uso
Frasch et al. Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model.
JPS61502957A (ja) 大腸菌のｌｔ―ｂエンテロトキシンサブユニットと莢膜ポリマーとの免疫原性結合体
Banerjee-Bhatnagar et al. Expression of Neisseria meningitidis iron-regulated outer membrane proteins, including a 70-kilodalton transferrin receptor, and their potential for use as vaccines
BR112015009541B1 (pt) novos adjuvantes de mucosa e sistemas de aplicação
Yang et al. Lactobacillus plantarum displaying conserved M2e and HA2 fusion antigens induces protection against influenza virus challenge
CN102140430A (zh) 一种不含抗性标记的鼠伤寒沙门氏菌基因缺失突变菌株、疫苗及应用
CN105175549B (zh) 一种流感嗜血杆菌融合蛋白及其构建方法与应用
PT88850B (pt) Processo de preparacao de vacina e de composicao contra a septicemia por e. coli em aves domesticas
CN108619501A (zh) 抗rsv和脑膜炎球菌缀合疫苗及其制备方法
Peak et al. Evaluation of truncated NhhA protein as a candidate meningococcal vaccine antigen
Nejati et al. Biological and immunological evaluation of Neisseria meningitidis serogroup A outer Membrane vesicle as vaccine candidates
Kim et al. Inactivated Vibrio cholerae strains that express TcpA via the toxT-139F allele induce antibody responses against TcpA
Vandemaele et al. Immunization with the biologically active lectin domain of PapGII induces strong adhesion-inhibiting antibody responses but not protection against avian pathogenic Escherichia coli
CN117551180A (zh) 变异链球菌复合抗原以及卵黄抗体的制备方法和应用
TW200418874A (en) Passive vaccine for the prevention of campylobacter colonization, and its preparation method
CN114073766A (zh) 一种幽门螺杆菌表位肽及其应用
CN104587461A (zh) 伤寒、甲型乙型副伤寒多糖蛋白结合型多价联合疫苗
CN108794585A (zh) 一种抗幽门螺杆菌的卵黄抗体制备方法及应用
RU2683027C2 (ru) Поливалентная иммунизирующая и/или терапевтическая композиция для применения при бактериальных инфекциях или пищевом отравлении, в частности сальмонеллёзе, способ получения этой композиции, её применение и вакцина, содержащая эту композицию
Mansour et al. Stimulating immunoglobulin response by intramuscular delivery of exopolysaccharides-adjuvanted mannheimiosis vaccine in goats
CN105214084A (zh) 一种龋齿疫苗及其制备方法